Induction of breast cancer stem cells by M1 macrophages through Lin-28B-let-7-HMGA2 axis-Reference-Cited by-同舟云学术

Induction of breast cancer stem cells by M1 macrophages through Lin-28B-let-7-HMGA2 axis

Published:2019-06 Issue: Volume:452 Page:213-225
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Guo Liang^ORCID,Cheng Xiang,Chen Hongyu,Chen Changguo,Xie Shuai,Zhao Min,Liu Dan,Deng Que,Liu Yanjun,Wang Xiaomeng,Chen Xintian,Wang Jiangong,Yin Zhaoyang,Qi Siyong,Gao Jiangping,Ma Yuanfang,Guo Ning,Shi Ming

Funder

National Key Technologies R&D Program for New Drugs

National High-Tech Research and Development Plan

National Natural Science Foundation of China

Beijing Natural Science Foundation

China Postdoctoral Science Foundation

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference67 articles.

1. Coordinated regulation of myeloid cells by tumours;Gabrilovich;Nat. Rev. Immunol.,2012

2. Human breast cancer cells educate macrophages toward the M2 activation status;Sousa;Breast Cancer Res.,2015

3. A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients;Zhang;J. Ovarian Res.,2014

4. The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer;Edin;PLoS One,2012

5. Opposite effects of M1 and M2 macrophage subtypes on lung cancer progression;Yuan;Sci. Rep.,2015

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of M1 (CD11c) and M2 (CD163) interplay in the pathogenesis of oral submucous fibrosis and its malignant transformation: An immunohistochemical analysis;Cytokine;2024-11

2. Sequential Responsive Multifunctional Nanomicelle Effectuates Collective Elimination of Breast Cancer and Cancer Stem Cells;Small;2024-08-30

3. The role of Lin28A and Lin28B in cancer beyond Let‐7;FEBS Letters;2024-08-16

4. Cancer stem cells: advances in knowledge and implications for cancer therapy;Signal Transduction and Targeted Therapy;2024-07-05

5. HMGA2 promotes resistance against paclitaxel by targeting the p53 signaling pathway in colorectal cancer cells;Heliyon;2024-06